RT Journal Article
SR Electronic
T1 Integrated transcriptomics and metabolomics reveal signatures of lipid metabolism dysregulation in HepaRG liver cells exposed to PCB 126
JF bioRxiv
FD Cold Spring Harbor Laboratory
SP 259093
DO 10.1101/259093
A1 Robin Mesnage
A1 Martina Biserni
A1 Sucharitha Balu
A1 Clément Frainay
A1 Nathalie Poupin
A1 Fabien Jourdan
A1 Eva Wozniak
A1 Theodoros Xenakis
A1 Charles A Mein
A1 Michael N Antoniou
YR 2018
UL http://biorxiv.org/content/early/2018/02/03/259093.abstract
AB Chemical pollutant exposure is a risk factor contributing to the growing epidemic of nonalcoholic fatty liver disease (NAFLD) affecting human populations that consume a Western diet. Although it is recognized that intoxication by chemical pollutants can lead to NAFLD, there is limited information available regarding the mechanism by which typical environmental levels of exposure can contribute to the onset of this disease. Here we describe the alterations in gene expression profiles and metabolite levels in the human hepatocyte HepaRG cell line, a validated model for cellular steatosis, exposed to the polychlorinated biphenyl (PCB) 126, one of the most potent chemical pollutants that can induce NAFLD. Sparse partial least squares classification of the molecular profiles revealed that exposure to PCB 126 provoked a decrease in polyunsaturated fatty acids as well as an increase in sphingolipid levels, concomitant with a decrease in the activity of genes involved in lipid metabolism. This was associated with an increased oxidative stress reflected by marked disturbances in taurine metabolism. A gene ontology analysis showed hallmarks of an activation of the AhR receptor by dioxin-like compounds. These changes in metabolome and transcriptome profiles were observed even at the lowest concentration (100 pM) of PCB 126 tested. A decrease in docosatrienoate levels was the most sensitive biomarker. Overall, our integrated multi-omics analysis provides mechanistic insight into how this class of chemical pollutant can cause NAFLD. Our study lays the foundation for the development of molecular signatures of toxic effects of chemicals causing fatty liver diseases to move away from a chemical risk assessment based on in vivo animal experiments.